What The Cloud Will Do For Medical Imaging
PACS and VNAs are the current image storage systems that are standard in healthcare. In such systems, it's common for digital imaging from X-rays, MRIs, and so on to be archived after a certain interval has passed. Most PACS (picture archiving and communication systems) offer an archive option. VNAs (vendor-neutral archives) are used to consolidate image files from various PACS solutions into a centralized, cross-platform storage volume.Cloud ServicesStorage hardware in the healthcare industry has been increasing in relative cost as more patient data is collected. HIPAA guidelines forretaining medical records are using up ...
Source: ePharma Summit - December 20, 2016 Category: Pharmaceuticals Source Type: blogs
What's Boehringer Ingelheim Doing on Pinterest?
What ' s Boehringer Ingelheim Doing on Pinterest? (Source: Pharma Marketing Blog)
Source: Pharma Marketing Blog - December 19, 2016 Category: Pharmaceuticals Tags: Boehringer Ingelheim Pinterest Source Type: blogs
Top Pharma Companies on Pinterest
According to ad agency AbelsonTaylor (AT), Pinterest has"enormous potential for healthcare marketing. Healthcare marketers should be engaging the outstanding attributes of Pinterest in their digital, e-commerce and social media marketing strategies and tactics" (read morehere). AT suggests the following types of content are appropriate for pharma marketing via Pinterest:Disease awareness (for clinicians and patients)History of disease/treatment (for clinicians and patients)Support groups/personal experiences (for consumers and patients)Product launch market preparation measures (for clinicians)Health association,...
Source: Pharma Marketing Blog - December 17, 2016 Category: Pharmaceuticals Tags: Pinterest Source Type: blogs
FDA Cites TV Ads for " Compelling " " Attention-Grabbing " Distractions That Undermine Communication of Risks
According to anuntitled letter FDA recently sent to Sanofi, all the fast-paced"grooving" going on in the “Mr. Groove” TV ad (here) for Toujeo makes it"difficult for consumers to adequately process and comprehend the risk information. The overall effect undermines the communication of the important risk information and thereby misleadingly minimizes the risks associated with the use of Toujeo." Moreover,"the presentation in the video is especially problematic from a public health perspective given the serious and potentially life-threatening risks associated with the drug.""Mr. Groovr&...
Source: Pharma Marketing Blog - December 15, 2016 Category: Pharmaceuticals Tags: Celgene DTC Advertising FDA Otezla Risk Communication Sanofi Toujeo TV untitled letters warning letters Source Type: blogs
[Free Whitepaper] The Future of Digital Health:Technological Advancements That Will Impact Big Pharma
As new technological advancements emerge, the pharmaceutical industry must adapt to changes in the market space. What will the future of health and care look like, particularly in the United States, as it pertains to innovation, commercialism and policy? In the first, of a three-part white paper series, we ’ve identified three areas that will be impacted by these technological advancements and the impact they will have on the industry. See what industry experts also had to say about the future of digital health.Key takeaways:Increasing the value propositionImplementing new strategies for doing old thingsC...
Source: ePharma Summit - December 14, 2016 Category: Pharmaceuticals Tags: Big Pharma Digital Health ePharma ePharma Summit innovation white paper Source Type: blogs
Drugs for Older Americans Rose an Average of 15.5% in 2015 According to AARP Report
Retail prices for brand name prescription drugs widely used by older Americans rose by an average of 15.5% in 2015 —almost 130 times faster than the 0.1% general inflation rate—according to a new AARP Public Policy Institute (PPI) report released today.Click on image for an enlarged viewAARP ’s Rx Price Watch Report: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans, 2006-2015, shows that the average annual cost for one brand name drug used on a chronic basis now exceeds $5,800. Five of the six drugs with the highest cumulative price increases over the study period were marketed...
Source: Pharma Marketing Blog - December 14, 2016 Category: Pharmaceuticals Tags: AARP Drug prices Valeant Source Type: blogs
Flowchart: How Pharma Can Handle Every Type of Comment on Social Media
With apologies toHealth Care Social Media Blog. (Source: Pharma Marketing Blog)
Source: Pharma Marketing Blog - December 13, 2016 Category: Pharmaceuticals Tags: social media Source Type: blogs
2016 Year in Review: Charts & Graphs
I heard on Twitter that no one wants to see your"Year in Review." @lucyboyen, for example, tweeted"I looked at my year in review and thought to myself you know who wants to see that? Absolutely nobody."Yes, 2016 was a lousy year for many people and even for the drug industry, but for different reasons. Yet if you look at the numbers, you will find some good news as well. So I feel justified in collecting together this Slideshare"2016 Year in Review" focusing on the many charts and graphs that I have published viaPharma Marketing News,Pharma Marketing Blog, and curated viaPharma Industry News U...
Source: Pharma Marketing Blog - December 12, 2016 Category: Pharmaceuticals Tags: 2016 Year in Review Source Type: blogs
21st Century Cures for Pharmaceutical Marketing
In what Public Citizen described as an"Early Gift for the Pharmaceutical Industry" (seehere), the Senate this week passed the 21st Century Cures Act (21st CC), which contains many provisions that will benefit the pharmaceutical industry and patients, according to many observers, including President Obama who said"We are now one step closer to ending cancer as we know it, unlocking cures for diseases like Alzheimer's..."The Act will also benefit pharma marketers and usher in a new era of pharmaceutical marketing. How so?Read more » (Source: Pharma Marketing Blog)
Source: Pharma Marketing Blog - December 9, 2016 Category: Pharmaceuticals Tags: 21st Century Cures Clinical Trials off-label promotion surrogates Source Type: blogs
FDA ’s Lax Enforcement Trend Continues
FDA continues to issue fewer and fewer warning and untitled letters. As of today (8 December 2016) FDA has issued only 5 enforcement letters (4 untitled and 1 warning letter) compared to 9 letters in 2015.Perhaps in 2017 FDA will issue no letters at all, especially if Trump has his way and Silicon Valley investor Jim O ’Neill becomes the new FDA Commissioner. O’Neill is not a scientist or physician so it ' s no wonder that he has proposed that the FDA only require companies to prove drugs are safe before they are sold – not that they actually work (readthis).The other trend I see is FDA caving in to forces that oppos...
Source: Pharma Marketing Blog - December 8, 2016 Category: Pharmaceuticals Tags: FDA warning letters Source Type: blogs
2016 Sees a Slight Uptick in FDA ’s Enforcement Actions
UPDATED 15 December 2016: A few days ago, I reported that FDA continues to issue fewer and fewer warning and untitled letters. When I wrote that (8 December 2016) FDA had issued only 5 enforcement letters (4 untitled and 1 warning letter) compared to 9 letters in 2015.This week on 12 and 13 December, FDA issued 4 new letters - 2 warning letters and 2 untitled letters - to bring the total to 9 letters for 2016. As the revised chart on the left shows, this equals the number of total letters FDA sent last year but this year, to date, FDA issued one more warning letter than it did last year. So, this could be considered a " sl...
Source: Pharma Marketing Blog - December 8, 2016 Category: Pharmaceuticals Tags: FDA warning letters Source Type: blogs
The Role of E-Health in the Lives of Older Adults
This study shows t hat technology-based health information can effectively promote health among older individuals.ACCESS TO HEALTHCARETechnology has also been used to increase access to healthcare especially for older adults and individuals living in rural areas. Many telehealth services have been extended to older adults to help increase theiraccess to healthcare. Though this method of providing care does not necessarily decreases healthcare costs, it increases patient satisfaction by allowing them to be monitored by nurses and doctors in the comfort of their home. Studies have found that these telehealth services have si...
Source: ePharma Summit - December 6, 2016 Category: Pharmaceuticals Tags: baby boomers eHealth ehealth apps Healthcare technology medical technology medtech mhealth Source Type: blogs
Can This Work for Pharma? The Continual Quest of Creative Advertisers
PM360 magazine is asking its readers find marketing campaigns and tactics used by consumer packaged goods, retail, and other industries to give pharma marketers some fresh ideas. Here's what one ad agency SVP Executive Creative Director came up with as and example of how pharma can"push the boundaries":Could This Work for Pharma? Inspiration from Outside Industries In terms of creepiness, this campaign has nothing over some creepy pharma campaigns I've seen (see, for example, my"Gallery of Scary Pharma Industry Advertising").According to the Creative Director who submitted this example to PM360,...
Source: Pharma Marketing Blog - December 2, 2016 Category: Pharmaceuticals Tags: creative DTC Advertising Source Type: blogs
FDA Compliant Diclegis Instagram Promo by (Good) Emily Maynard Johnson Can't Compete with (Bad) Kim Kardashian's Violative Post
About 22 weeks ago, Emily Maynard Johnson, who appeared on ABC'sThe Bachelor and The Bachelorette, posted the following Diclegis promotion to her Instagram account:I assume you've noticed that all the ISI (Important Safety Information) and side effects are mentioned either through links or, more importantly, within the post itself (you have to scroll down to see it).This is in contrast to Kim Kardashian's Diclegis Instagram promotion that made news last year. That ad drew a prompt warning letter from the FDA to Duchesnay USA, which markets the drug, because the post did not mention nor did it link to any ISI or...
Source: Pharma Marketing Blog - November 30, 2016 Category: Pharmaceuticals Tags: Diclegis Instagram Source Type: blogs
Ritesh Patel Joins as Keynote for ePharma Summit 2017
Ogilvy's Chief Digital Officer, Ritesh Patel, has officially joined among the growing list of health care professionals and digital marketers expected to speak at our annual ePharma Summit 2017.Prior to Ogilvy, Ritesh spent 5 years as the Global Head of Digital and Innovation for inVentiv Health, a global healthcare services organization with offices in 40 countries.What can you expect to hear from Patel? The digital marketing expert will focusing on the IoTFor more information on Mr. Patel and his professional background, please visit our website>>> goo.gl/OVNqObThis year, the three-day summit will kick off...
Source: ePharma Summit - November 29, 2016 Category: Pharmaceuticals Tags: 2017 epharma summit Digital Innovation digital marketing epharma 2017 keynote pharma marketing ritesh patel Source Type: blogs
